Titre : Xanthènes

Xanthènes : Questions médicales fréquentes

Termes MeSH sélectionnés :

Length of Stay

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer une intoxication aux xanthènes ?

Le diagnostic repose sur l'historique d'exposition et des tests sanguins spécifiques.
Intoxication Tests de laboratoire
#2

Quels tests sont utilisés pour détecter les xanthènes ?

Des analyses chromatographiques comme la HPLC sont couramment utilisées.
Chromatographie Analyse chimique
#3

Quels symptômes indiquent une exposition aux xanthènes ?

Les symptômes incluent des nausées, des vertiges et des troubles neurologiques.
Symptômes Neurologie
#4

Les xanthènes peuvent-ils être détectés dans l'urine ?

Oui, des tests urinaires peuvent révéler la présence de xanthènes.
Analyse d'urine Détection
#5

Quel rôle joue l'historique médical dans le diagnostic ?

L'historique aide à identifier les expositions antérieures aux xanthènes.
Historique médical Exposition

Symptômes 5

#1

Quels sont les symptômes courants d'une exposition aux xanthènes ?

Les symptômes incluent des maux de tête, des nausées et des troubles de la vision.
Maux de tête Nausées
#2

Les xanthènes provoquent-ils des réactions allergiques ?

Oui, certaines personnes peuvent développer des réactions allergiques aux xanthènes.
Réaction allergique Allergies
#3

Comment les xanthènes affectent-ils le système nerveux ?

Ils peuvent provoquer des troubles neurologiques comme des convulsions ou des tremblements.
Système nerveux Convulsions
#4

Les symptômes varient-ils selon le type de xanthène ?

Oui, les symptômes peuvent varier selon la structure chimique des xanthènes.
Chimie organique Variabilité des symptômes
#5

Les xanthènes affectent-ils la peau ?

Oui, une exposition cutanée peut entraîner des irritations ou des éruptions.
Irritation cutanée Dermatologie

Prévention 5

#1

Comment prévenir l'exposition aux xanthènes ?

Évitez les produits contenant des xanthènes et portez des équipements de protection.
Prévention Équipements de protection
#2

Les travailleurs doivent-ils être formés sur les xanthènes ?

Oui, une formation sur les risques et la manipulation sécurisée est essentielle.
Formation professionnelle Sécurité au travail
#3

Quelles mesures de sécurité doivent être prises en laboratoire ?

Utilisez des hottes, des gants et des lunettes de protection lors de la manipulation.
Sécurité en laboratoire Équipements de protection
#4

Les xanthènes sont-ils réglementés ?

Oui, leur utilisation est souvent réglementée pour protéger la santé publique.
Réglementation Santé publique
#5

Comment informer le public sur les dangers des xanthènes ?

Des campagnes de sensibilisation et des brochures d'information peuvent être utiles.
Sensibilisation Éducation à la santé

Traitements 5

#1

Quel traitement est recommandé en cas d'intoxication aux xanthènes ?

Le traitement inclut l'élimination de l'exposition et des soins symptomatiques.
Intoxication Soins médicaux
#2

Des antidotes existent-ils pour les xanthènes ?

Actuellement, il n'existe pas d'antidote spécifique pour les xanthènes.
Antidotes Toxicologie
#3

Comment traiter les symptômes neurologiques causés par les xanthènes ?

Des médicaments anticonvulsivants peuvent être utilisés pour gérer les symptômes.
Anticonvulsivants Neurologie
#4

Les soins de soutien sont-ils nécessaires ?

Oui, des soins de soutien sont souvent nécessaires pour les cas graves.
Soins de soutien Toxicologie
#5

Peut-on utiliser des traitements naturels contre les xanthènes ?

Il n'existe pas de preuves solides pour des traitements naturels efficaces.
Médecine alternative Efficacité des traitements

Complications 5

#1

Quelles complications peuvent survenir après une exposition aux xanthènes ?

Des complications neurologiques et dermatologiques peuvent se développer.
Complications Neurologie
#2

Les xanthènes peuvent-ils causer des maladies chroniques ?

Une exposition prolongée peut augmenter le risque de maladies chroniques.
Maladies chroniques Exposition prolongée
#3

Y a-t-il des effets à long terme des xanthènes ?

Oui, des effets à long terme incluent des troubles cognitifs et des problèmes de santé.
Effets à long terme Santé cognitive
#4

Les xanthènes peuvent-ils affecter la reproduction ?

Certaines études suggèrent qu'ils peuvent avoir des effets néfastes sur la reproduction.
Santé reproductive Toxicologie
#5

Comment gérer les complications liées aux xanthènes ?

Un suivi médical régulier et des traitements symptomatiques sont recommandés.
Suivi médical Traitements symptomatiques

Facteurs de risque 5

#1

Qui est le plus à risque d'exposition aux xanthènes ?

Les travailleurs dans l'industrie chimique et les laboratoires sont les plus à risque.
Travailleurs Industrie chimique
#2

Les enfants sont-ils plus vulnérables aux xanthènes ?

Oui, les enfants peuvent être plus sensibles aux effets toxiques des xanthènes.
Enfants Sensibilité
#3

Quels facteurs environnementaux augmentent le risque ?

La pollution et l'exposition à des produits chimiques augmentent le risque.
Pollution Environnement
#4

Les antécédents médicaux influencent-ils le risque ?

Oui, des antécédents de maladies respiratoires ou neurologiques augmentent le risque.
Antécédents médicaux Maladies respiratoires
#5

Les habitudes de vie jouent-elles un rôle dans le risque ?

Oui, des habitudes comme le tabagisme peuvent augmenter la vulnérabilité aux xanthènes.
Habitudes de vie Tabagisme
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Xanthènes : Questions médicales les plus fréquentes", "headline": "Xanthènes : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Xanthènes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-07", "dateModified": "2025-05-02", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Xanthènes" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Composés hétérocycliques 3 noyaux", "url": "https://questionsmedicales.fr/mesh/D006575", "about": { "@type": "MedicalCondition", "name": "Composés hétérocycliques 3 noyaux", "code": { "@type": "MedicalCode", "code": "D006575", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Propanthéline", "alternateName": "Propantheline", "url": "https://questionsmedicales.fr/mesh/D011413", "about": { "@type": "MedicalCondition", "name": "Propanthéline", "code": { "@type": "MedicalCode", "code": "D011413", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.558" } } }, { "@type": "MedicalWebPage", "name": "Pyronine", "alternateName": "Pyronine", "url": "https://questionsmedicales.fr/mesh/D011754", "about": { "@type": "MedicalCondition", "name": "Pyronine", "code": { "@type": "MedicalCode", "code": "D011754", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.570" } } }, { "@type": "MedicalWebPage", "name": "Rhodamines", "alternateName": "Rhodamines", "url": "https://questionsmedicales.fr/mesh/D012235", "about": { "@type": "MedicalCondition", "name": "Rhodamines", "code": { "@type": "MedicalCode", "code": "D012235", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.600" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Rhodamine 123", "alternateName": "Rhodamine 123", "url": "https://questionsmedicales.fr/mesh/D020112", "about": { "@type": "MedicalCondition", "name": "Rhodamine 123", "code": { "@type": "MedicalCode", "code": "D020112", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.600.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Thioxanthènes", "alternateName": "Thioxanthenes", "url": "https://questionsmedicales.fr/mesh/D013892", "about": { "@type": "MedicalCondition", "name": "Thioxanthènes", "code": { "@type": "MedicalCode", "code": "D013892", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.704" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Chlorprothixène", "alternateName": "Chlorprothixene", "url": "https://questionsmedicales.fr/mesh/D002749", "about": { "@type": "MedicalCondition", "name": "Chlorprothixène", "code": { "@type": "MedicalCode", "code": "D002749", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.704.250" } } }, { "@type": "MedicalWebPage", "name": "Clopenthixol", "alternateName": "Clopenthixol", "url": "https://questionsmedicales.fr/mesh/D003006", "about": { "@type": "MedicalCondition", "name": "Clopenthixol", "code": { "@type": "MedicalCode", "code": "D003006", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.704.269" } } }, { "@type": "MedicalWebPage", "name": "Flupentixol", "alternateName": "Flupenthixol", "url": "https://questionsmedicales.fr/mesh/D005475", "about": { "@type": "MedicalCondition", "name": "Flupentixol", "code": { "@type": "MedicalCode", "code": "D005475", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.704.360" } } }, { "@type": "MedicalWebPage", "name": "Hycanthone", "alternateName": "Hycanthone", "url": "https://questionsmedicales.fr/mesh/D006826", "about": { "@type": "MedicalCondition", "name": "Hycanthone", "code": { "@type": "MedicalCode", "code": "D006826", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.704.450" } } }, { "@type": "MedicalWebPage", "name": "Tiotixène", "alternateName": "Thiothixene", "url": "https://questionsmedicales.fr/mesh/D013888", "about": { "@type": "MedicalCondition", "name": "Tiotixène", "code": { "@type": "MedicalCode", "code": "D013888", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.704.787" } } } ] }, { "@type": "MedicalWebPage", "name": "Xanthones", "alternateName": "Xanthones", "url": "https://questionsmedicales.fr/mesh/D044004", "about": { "@type": "MedicalCondition", "name": "Xanthones", "code": { "@type": "MedicalCode", "code": "D044004", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.852" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Lucanthone", "alternateName": "Lucanthone", "url": "https://questionsmedicales.fr/mesh/D008154", "about": { "@type": "MedicalCondition", "name": "Lucanthone", "code": { "@type": "MedicalCode", "code": "D008154", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.953.852.388" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Xanthènes", "alternateName": "Xanthenes", "code": { "@type": "MedicalCode", "code": "D014966", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Hongji Li", "url": "https://questionsmedicales.fr/author/Hongji%20Li", "affiliation": { "@type": "Organization", "name": "Key Laboratory of Green and Precise Synthetic Chemistry and Applications, Ministry of Education, School of Chemistry and Materials Science, Huaibei Normal University, Huaibei, Anhui 235000, P. R. China." } }, { "@type": "Person", "name": "Steven R Gwaltney", "url": "https://questionsmedicales.fr/author/Steven%20R%20Gwaltney", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Mississippi State University, Mississippi State, Mississippi 39762, United States." } }, { "@type": "Person", "name": "Colleen N Scott", "url": "https://questionsmedicales.fr/author/Colleen%20N%20Scott", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, Mississippi State University, Mississippi State, Mississippi 39762, United States." } }, { "@type": "Person", "name": "Ramalingam Manivannan", "url": "https://questionsmedicales.fr/author/Ramalingam%20Manivannan", "affiliation": { "@type": "Organization", "name": "Department of Advanced Organic Materials Engineering, Chungnam National University, 220 Gung-dong, Yuseong-gu, Daejeon, 305-764, South Korea." } }, { "@type": "Person", "name": "Young-A Son", "url": "https://questionsmedicales.fr/author/Young-A%20Son", "affiliation": { "@type": "Organization", "name": "Department of Advanced Organic Materials Engineering, Chungnam National University, 220 Gung-dong, Yuseong-gu, Daejeon, 305-764, South Korea. yason@cnu.ac.kr." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Effect of Instrumented Spine Surgery on Length of Stay.", "datePublished": "2023-05-15", "url": "https://questionsmedicales.fr/article/37186578", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.5435/JAAOSGlobal-D-22-00231" } }, { "@type": "ScholarlyArticle", "name": "Perioperative risk factors impact on intensive care unit length of stay (ICU length of stay) in oral squamous cell carcinoma.", "datePublished": "2023-09-01", "url": "https://questionsmedicales.fr/article/37658335", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12903-023-03304-4" } }, { "@type": "ScholarlyArticle", "name": "Frailty, length of stay and cost in hip fracture patients.", "datePublished": "2022-10-05", "url": "https://questionsmedicales.fr/article/36197493", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00198-022-06553-1" } }, { "@type": "ScholarlyArticle", "name": "Length of Stay in Patients Undergoing Tracheoplasty: A NSQIP Study.", "datePublished": "2022-10-10", "url": "https://questionsmedicales.fr/article/36214517", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/lary.30424" } }, { "@type": "ScholarlyArticle", "name": "Genetic Testing and Hospital Length of Stay in Neonates With Epilepsy.", "datePublished": "2022-06-02", "url": "https://questionsmedicales.fr/article/35751960", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.pediatrneurol.2022.05.011" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Composés hétérocycliques à cycles fusionnés", "item": "https://questionsmedicales.fr/mesh/D000072471" }, { "@type": "ListItem", "position": 4, "name": "Composés hétérocycliques 3 noyaux", "item": "https://questionsmedicales.fr/mesh/D006575" }, { "@type": "ListItem", "position": 5, "name": "Xanthènes", "item": "https://questionsmedicales.fr/mesh/D014966" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Xanthènes - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Xanthènes", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Xanthènes", "description": "Comment diagnostiquer une intoxication aux xanthènes ?\nQuels tests sont utilisés pour détecter les xanthènes ?\nQuels symptômes indiquent une exposition aux xanthènes ?\nLes xanthènes peuvent-ils être détectés dans l'urine ?\nQuel rôle joue l'historique médical dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D014966?mesh_terms=Length+of+Stay#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Xanthènes", "description": "Quels sont les symptômes courants d'une exposition aux xanthènes ?\nLes xanthènes provoquent-ils des réactions allergiques ?\nComment les xanthènes affectent-ils le système nerveux ?\nLes symptômes varient-ils selon le type de xanthène ?\nLes xanthènes affectent-ils la peau ?", "url": "https://questionsmedicales.fr/mesh/D014966?mesh_terms=Length+of+Stay#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Xanthènes", "description": "Comment prévenir l'exposition aux xanthènes ?\nLes travailleurs doivent-ils être formés sur les xanthènes ?\nQuelles mesures de sécurité doivent être prises en laboratoire ?\nLes xanthènes sont-ils réglementés ?\nComment informer le public sur les dangers des xanthènes ?", "url": "https://questionsmedicales.fr/mesh/D014966?mesh_terms=Length+of+Stay#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Xanthènes", "description": "Quel traitement est recommandé en cas d'intoxication aux xanthènes ?\nDes antidotes existent-ils pour les xanthènes ?\nComment traiter les symptômes neurologiques causés par les xanthènes ?\nLes soins de soutien sont-ils nécessaires ?\nPeut-on utiliser des traitements naturels contre les xanthènes ?", "url": "https://questionsmedicales.fr/mesh/D014966?mesh_terms=Length+of+Stay#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Xanthènes", "description": "Quelles complications peuvent survenir après une exposition aux xanthènes ?\nLes xanthènes peuvent-ils causer des maladies chroniques ?\nY a-t-il des effets à long terme des xanthènes ?\nLes xanthènes peuvent-ils affecter la reproduction ?\nComment gérer les complications liées aux xanthènes ?", "url": "https://questionsmedicales.fr/mesh/D014966?mesh_terms=Length+of+Stay#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Xanthènes", "description": "Qui est le plus à risque d'exposition aux xanthènes ?\nLes enfants sont-ils plus vulnérables aux xanthènes ?\nQuels facteurs environnementaux augmentent le risque ?\nLes antécédents médicaux influencent-ils le risque ?\nLes habitudes de vie jouent-elles un rôle dans le risque ?", "url": "https://questionsmedicales.fr/mesh/D014966?mesh_terms=Length+of+Stay#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication aux xanthènes ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique d'exposition et des tests sanguins spécifiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les xanthènes ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses chromatographiques comme la HPLC sont couramment utilisées." } }, { "@type": "Question", "name": "Quels symptômes indiquent une exposition aux xanthènes ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des nausées, des vertiges et des troubles neurologiques." } }, { "@type": "Question", "name": "Les xanthènes peuvent-ils être détectés dans l'urine ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests urinaires peuvent révéler la présence de xanthènes." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique aide à identifier les expositions antérieures aux xanthènes." } }, { "@type": "Question", "name": "Quels sont les symptômes courants d'une exposition aux xanthènes ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des maux de tête, des nausées et des troubles de la vision." } }, { "@type": "Question", "name": "Les xanthènes provoquent-ils des réactions allergiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines personnes peuvent développer des réactions allergiques aux xanthènes." } }, { "@type": "Question", "name": "Comment les xanthènes affectent-ils le système nerveux ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent provoquer des troubles neurologiques comme des convulsions ou des tremblements." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de xanthène ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon la structure chimique des xanthènes." } }, { "@type": "Question", "name": "Les xanthènes affectent-ils la peau ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une exposition cutanée peut entraîner des irritations ou des éruptions." } }, { "@type": "Question", "name": "Comment prévenir l'exposition aux xanthènes ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les produits contenant des xanthènes et portez des équipements de protection." } }, { "@type": "Question", "name": "Les travailleurs doivent-ils être formés sur les xanthènes ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une formation sur les risques et la manipulation sécurisée est essentielle." } }, { "@type": "Question", "name": "Quelles mesures de sécurité doivent être prises en laboratoire ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Utilisez des hottes, des gants et des lunettes de protection lors de la manipulation." } }, { "@type": "Question", "name": "Les xanthènes sont-ils réglementés ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, leur utilisation est souvent réglementée pour protéger la santé publique." } }, { "@type": "Question", "name": "Comment informer le public sur les dangers des xanthènes ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des campagnes de sensibilisation et des brochures d'information peuvent être utiles." } }, { "@type": "Question", "name": "Quel traitement est recommandé en cas d'intoxication aux xanthènes ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut l'élimination de l'exposition et des soins symptomatiques." } }, { "@type": "Question", "name": "Des antidotes existent-ils pour les xanthènes ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas d'antidote spécifique pour les xanthènes." } }, { "@type": "Question", "name": "Comment traiter les symptômes neurologiques causés par les xanthènes ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments anticonvulsivants peuvent être utilisés pour gérer les symptômes." } }, { "@type": "Question", "name": "Les soins de soutien sont-ils nécessaires ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des soins de soutien sont souvent nécessaires pour les cas graves." } }, { "@type": "Question", "name": "Peut-on utiliser des traitements naturels contre les xanthènes ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de preuves solides pour des traitements naturels efficaces." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après une exposition aux xanthènes ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications neurologiques et dermatologiques peuvent se développer." } }, { "@type": "Question", "name": "Les xanthènes peuvent-ils causer des maladies chroniques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Une exposition prolongée peut augmenter le risque de maladies chroniques." } }, { "@type": "Question", "name": "Y a-t-il des effets à long terme des xanthènes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets à long terme incluent des troubles cognitifs et des problèmes de santé." } }, { "@type": "Question", "name": "Les xanthènes peuvent-ils affecter la reproduction ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent qu'ils peuvent avoir des effets néfastes sur la reproduction." } }, { "@type": "Question", "name": "Comment gérer les complications liées aux xanthènes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical régulier et des traitements symptomatiques sont recommandés." } }, { "@type": "Question", "name": "Qui est le plus à risque d'exposition aux xanthènes ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les travailleurs dans l'industrie chimique et les laboratoires sont les plus à risque." } }, { "@type": "Question", "name": "Les enfants sont-ils plus vulnérables aux xanthènes ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants peuvent être plus sensibles aux effets toxiques des xanthènes." } }, { "@type": "Question", "name": "Quels facteurs environnementaux augmentent le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "La pollution et l'exposition à des produits chimiques augmentent le risque." } }, { "@type": "Question", "name": "Les antécédents médicaux influencent-ils le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de maladies respiratoires ou neurologiques augmentent le risque." } }, { "@type": "Question", "name": "Les habitudes de vie jouent-elles un rôle dans le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes comme le tabagisme peuvent augmenter la vulnérabilité aux xanthènes." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 02/05/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Hongji Li

3 publications dans cette catégorie

Affiliations :
  • Key Laboratory of Green and Precise Synthetic Chemistry and Applications, Ministry of Education, School of Chemistry and Materials Science, Huaibei Normal University, Huaibei, Anhui 235000, P. R. China.

Steven R Gwaltney

3 publications dans cette catégorie

Affiliations :
  • Department of Chemistry, Mississippi State University, Mississippi State, Mississippi 39762, United States.
Publications dans "Xanthènes" :

Colleen N Scott

3 publications dans cette catégorie

Affiliations :
  • Department of Chemistry, Mississippi State University, Mississippi State, Mississippi 39762, United States.
Publications dans "Xanthènes" :

Ramalingam Manivannan

3 publications dans cette catégorie

Affiliations :
  • Department of Advanced Organic Materials Engineering, Chungnam National University, 220 Gung-dong, Yuseong-gu, Daejeon, 305-764, South Korea.
Publications dans "Xanthènes" :

Young-A Son

3 publications dans cette catégorie

Affiliations :
  • Department of Advanced Organic Materials Engineering, Chungnam National University, 220 Gung-dong, Yuseong-gu, Daejeon, 305-764, South Korea. yason@cnu.ac.kr.
Publications dans "Xanthènes" :

Cliff I Stains

2 publications dans cette catégorie

Affiliations :
  • Department of Chemistry, University of Virginia, Charlottesville, VA, 22904, USA.
  • University of Virgnia Cancer Center, University of Virginia, Charlottesville, VA, 22904, USA.
Publications dans "Xanthènes" :

Evan W Miller

2 publications dans cette catégorie

Affiliations :
  • Department of Chemistry, University of California, Berkeley, CA, 94720, USA. evanwmiller@berkeley.edu.
  • Department of Molecular & Cell Biology, University of California, Berkeley, CA, 94720, USA.
  • Helen Wills Neuroscience Institute, University of California, Berkeley, CA, 94720, USA.
Publications dans "Xanthènes" :

Si Chen

2 publications dans cette catégorie

Affiliations :
  • Department of Medicinal Chemistry, State Key Laboratory of Bioactive Substance and Function of Natural Medicines & Beijing Key Laboratory of Active Substances Discovery and Drugability Evaluation, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100050, China.

Hui Gao

2 publications dans cette catégorie

Affiliations :
  • Key Laboratory of Green and Precise Synthetic Chemistry and Applications, Ministry of Education, School of Chemistry and Materials Science, Huaibei Normal University, Huaibei, Anhui 235000, P. R. China.
  • Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Guangxi Normal University, Guilin 541004, P. R. China.
Publications dans "Xanthènes" :

Tao Miao

2 publications dans cette catégorie

Affiliations :
  • Key Laboratory of Green and Precise Synthetic Chemistry and Applications, Ministry of Education, School of Chemistry and Materials Science, Huaibei Normal University, Huaibei, Anhui 235000, P. R. China.
Publications dans "Xanthènes" :

Elma Veljović

2 publications dans cette catégorie

Affiliations :
  • University of Sarajevo, Faculty of Pharmacy, 71000Sarajevo, Bosnia and Herzegovina.

Selma Špirtović-Halilović

2 publications dans cette catégorie

Affiliations :
  • University of Sarajevo, Faculty of Pharmacy, 71000Sarajevo, Bosnia and Herzegovina.

Amar Osmanović

2 publications dans cette catégorie

Affiliations :
  • University of Sarajevo, Faculty of Pharmacy, 71000Sarajevo, Bosnia and Herzegovina.

Davorka Završnik

2 publications dans cette catégorie

Affiliations :
  • University of Sarajevo, Faculty of Pharmacy, 71000Sarajevo, Bosnia and Herzegovina.

Frederik Brøndsted

2 publications dans cette catégorie

Affiliations :
  • Department of Chemistry, University of Virginia, Charlottesville, VA, USA.
Publications dans "Xanthènes" :

Chathuranga S L Rathnamalala

2 publications dans cette catégorie

Affiliations :
  • Department of Chemistry, Mississippi State University, Mississippi State, Mississippi 39762, United States.
Publications dans "Xanthènes" :

Jefferson Chan

2 publications dans cette catégorie

Affiliations :
  • Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, United States.
Publications dans "Xanthènes" :

Petr Klán

2 publications dans cette catégorie

Affiliations :
  • Masaryk University Faculty of Science: Masarykova univerzita Prirodovedecka Fakulta, Department of Chemistry, Kamenice 5, 62500, Brno, CZECH REPUBLIC.
Publications dans "Xanthènes" :

Saira Naseem

2 publications dans cette catégorie

Affiliations :
  • Institute of Chemical Sciences, Bahauddin Zakariya University, Multan, Pakistan.

Zahid Shafiq

2 publications dans cette catégorie

Affiliations :
  • Institute of Chemical Sciences, Bahauddin Zakariya University, Multan, Pakistan.
  • Department of Pharmaceutical & Medicinal Chemistry, University of Bonn, Bonn, Germany.

Sources (8571 au total)

Effect of Instrumented Spine Surgery on Length of Stay.

Total joint arthroplasty studies have identified that surgeries that take place later in the week have a longer length of stay compared with those earlier in the week. This has not been demonstrated i... All instrumented spine surgeries in 2019 at a single academic tertiary center were retrospectively reviewed. Patients were categorized for surgical day and discharge disposition to home or a rehabilit... Seven hundred six patients were included in the analysis. Excluding Saturday, there were no differences in length of stay based on the day of surgery. Age older than 75 years, female, American Society... Day of surgery does not affect length of stay in instrumented spine surgeries. Discharge to a rehabilitation facility, however, did increase the length of stay as did age older than 75 years, higher A...

Perioperative risk factors impact on intensive care unit length of stay (ICU length of stay) in oral squamous cell carcinoma.

The trend in postoperative care for free flap patients is to deescalate from routine ICU admission into a specialty recovery unit. This study aims to investigate the predictive parameters in a routine... All patients who underwent ablative surgery for OSCC with free flap reconstruction and were managed in the ICU were included in this study. The primary outcome was ICU-length of stay. Perioperative, o... The study included 136 homogeneous patients, with a mean ICU length of stay of 4.5 (± 4.43 day). Patients with pre-operative positive renal dysfunction (P = 0.004), peripheral vascular disease (P < 0.... Patients with perioperative severe renal dysfunction, peripheral vascular disease, postoperative complication or high NYHA class are prone to have a significantly longer ICU length of stay. Several fa...

Frailty, length of stay and cost in hip fracture patients.

A hip fracture causes high morbidity and mortality. Frailty is associated with adverse outcomes and increased costs. Frailty measured using the Hospital Frailty Risk Score (HFRS) is associated with hi... Hip fractures account for an increasing number of hospital admissions around the world and are associated with high rates of morbidity and mortality. Frailty is increasingly recognized to be associate... A retrospective analysis was performed on 1014 patients ≥ 60 years who presented with a hip fracture between January 2016 to June 2020. Each patient was classified into HFRS low, intermediate or high ... Median total hospitalization costs were significantly higher in the highest HFRS (SGD$22,432) patients as compared to intermediate (SGD$18,759) and low HFRS (SGD$15,671) patients. The difference betwe... Frailty is associated with a marked increase in total costs in hip fracture patients. HFRS proved useful in estimating LOS and outcomes for older patients with hip fractures....

Length of Stay in Patients Undergoing Tracheoplasty: A NSQIP Study.

Prolonged length of stay (LOS) has been associated with increased morbidity and resource utilization in various surgical procedures. We aim to determine factors associated with increased hospital stay... The 2012-2018 National Surgical Quality Improvement Program (NSQIP) database was queried for patients undergoing tracheoplasty. Patient LOS was the primary clinical outcome. A LOS >75th percentile was... A total of 252 patients were queried. The majority of patients were female (67.5%), white (82.4%), and over the age of 65 (77.0%). Patients had a median LOS of 7 days with the 75th percentile cutoff b... This study elucidates factors associated with prolonged LOS in patients undergoing tracheoplasty. Patients with COPD and chronic steroid use were significantly associated with prolonged LOS.... 4 Laryngoscope, 133:1938-1942, 2023....

Genetic Testing and Hospital Length of Stay in Neonates With Epilepsy.

We evaluated changes in genetic testing for neonatal-onset epilepsy and associated short-term outcomes over an 8-year period among a cohort of patients in the neonatal intensive care unit (NICU) at a ... Our primary outcome was a change in length of stay (LOS) after 2018. We also ascertained severity of illness with the Neonatal Sequential Organ Failure Assessment (nSOFA), type and result of genetic t... Fifty-three infants with genetic testing were included; 20 infants were tested after 2018. A total of 4160 infants in the NICU without genetic testing were used as reference. In the genetic testing gr... In this cohort, changes in genetic testing for neonatal-onset epilepsy were associated with shorter LOS that was not explained by changes in severity of illness, birth weight, or the average LOS in th...

[Laboratories as predictors of length of hospital stay in patients with pneumonia].

There are several factors that influence the length of hospital stay (LoHS) in patients with community-acquired pneumonia (CAP). There is currently no study in the literature that correlates laborator... To find the association of laboratory parameters with the LoHS in patients with community-acquired pneumonia.... An observational, prospective, longitudinal, and controlled study was conducted in the emergency room of a secondary level hospital.... The mean time of LoHS in patients with CAP was 6.6 ± 3.0 days. The parameters of laboratory of monocytes, basophils and segmented neutrophils presented a correlation (Spearman rho) of 0.363, 0.364 and... LoHS in patients with CAP is related to the counting of monocytes, basophils, and neutrophils at the time of the hospital admittance and it was increased in patients with SAH and patients with COPD....

Laparoscopy in high-risk emergency general surgery reduces intensive care stay, length of stay and mortality.

Emergency general surgery patients undergoing laparoscopic surgery are at reduced risk of mortality and may require reduced length of critical care stay. This study investigated the effect of laparosc... Data were retrieved for all patients entered into the NELA database between 2013 and 2018. Only high-risk surgical patients (P-POSSUM predicted mortality risk of ≥ 5%) were included. Patients undergoi... A total of 66,517 high-risk patients received emergency major abdominal surgery. A laparoscopic procedure was attempted in 6998 (10.5%); of these, the procedure was competed laparoscopically in 3492 (... The results of this study suggest that in patients at high risk of post-operative mortality, laparoscopic emergency bowel surgery leads to a reduced length of critical care stay, overall length of sta...

Factors associated with an extended length of stay in the pediatric burn patient.

The Center for Medicaid and Medicare Services predicts the length of stay for pediatric burn patients based on several variables. However, many patients exceed their anticipated length. This study loo... We conducted a retrospective chart review of 535 pediatric burn patients admitted to our academic hospital from January 2018 to December 2020. 405 patients met inclusion criteria. Data were collected ... Average patient age was 3.36 years. 72.3% were treated for scald burns. Average length of stay was 13.5 days. 20.5% (n = 83) of patients exceeded their predicted length of stay. In comparing patients ... Twenty percent of pediatric burn patients had a longer length of stay than predicted by the Center for Medicaid and Medicare Services. Many factors were strongly associated with a longer-than-predicte...

Qualitative Analysis of Length of Stay and Readmission after Carotid Endarterectomy.

Length of stay (LOS) and readmissions are common measures to evaluate quality of health care. The objective of this study was to evaluate factors related to hospital LOS and readmission within 90 days... Using a single institution database, patients who underwent CEA for carotid stenosis between 2014 and 2019 were identified. Asymptomatic carotid stenosis (no history of any stroke or transient ischemi... There were 125 patients identified who underwent CEA for 133 carotid stenosis, and 8 patients had bilateral CEA; of which 36.8% were asymptomatic carotid stenosis with the remaining being operated on ... More than half of patients undergoing CEA for carotid stenosis were discharged after postoperative day 1. Interventions on modifiable clinical risk factors, such as morning CEA scheduling and manageme...

Association of Prophylaxis and Length of Stay With Venous Thromboembolism in Abdominopelvic Surgery.

Extended venous thromboembolism prophylaxis (eVTEp) is recommended for select patients who have undergone major abdominopelvic surgery to prevent postdischarge venous thromboembolism (pdVTE). Criteria... A retrospective cohort study of patients undergoing abdominopelvic surgery from January 2016 to February 2020 was performed using data from the Michigan Surgical Quality Collaborative. pdVTE was the m... A total of 45,637 patients underwent abdominopelvic surgery. Of which, 3063 (6.71%) were prescribed eVTEp. Two hundred eighty-five (0.62%) had pdVTE. Of the 285, 59 (21%) patients received eVTEp, whil... pdVTE was associated with increasing LOS but not with other VTE risk factors after propensity score matching. Current guidelines for eVTEp do not include LOS. Our findings suggest that LOS >5 d should...